NO20064422L - Krystallinske former av 5,11-dihydro-11-etyl-5-metyl-8{2-{(1-oksido-4-kinolin 1)oksy}etyl}-6H-dipyrido[3,2-B:2',3'-E][1,4]diazepin--on - Google Patents
Krystallinske former av 5,11-dihydro-11-etyl-5-metyl-8{2-{(1-oksido-4-kinolin 1)oksy}etyl}-6H-dipyrido[3,2-B:2',3'-E][1,4]diazepin--onInfo
- Publication number
- NO20064422L NO20064422L NO20064422A NO20064422A NO20064422L NO 20064422 L NO20064422 L NO 20064422L NO 20064422 A NO20064422 A NO 20064422A NO 20064422 A NO20064422 A NO 20064422A NO 20064422 L NO20064422 L NO 20064422L
- Authority
- NO
- Norway
- Prior art keywords
- ethyl
- dipyrido
- diazepin
- oxido
- dihydro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
LØSNINGSSAMMENSETNING AV 5,11 -DIHYDRO-11 -ETYL-5-METYL-8-{2-{(1 -OKSIDO-4-KINOLINYL)OKSY}ETYL}-6H-DIPYRIDO[3,2-B 2',3'-E][1,4] DIAZEPIN-6-ON, FORM I, FORM III OG DIHYDRAT I ETANOL, SOM EN FUNKSJON AV VANNINNHOLD VED 25 GRADER C Fasediagram over 5,11-dihydro-11-etyl-5-metyl-8-{2-{(1-oksido-4-kinolinyl)oksy}etyl}-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-on. Dihydratform og vannfrie krystallinsk former av 5,11-dihydro-11-etyl-5-metyl-8-{2-{(1-oksido-4-kinolinyl)oksy}etyl}-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-on.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US55935404P | 2004-04-02 | 2004-04-02 | |
PCT/US2005/009655 WO2005097796A2 (en) | 2004-04-02 | 2005-03-23 | Crystalline forms of 5,11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20064422L true NO20064422L (no) | 2006-09-29 |
Family
ID=34963561
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20064422A NO20064422L (no) | 2004-04-02 | 2006-09-29 | Krystallinske former av 5,11-dihydro-11-etyl-5-metyl-8{2-{(1-oksido-4-kinolin 1)oksy}etyl}-6H-dipyrido[3,2-B:2',3'-E][1,4]diazepin--on |
Country Status (19)
Country | Link |
---|---|
US (1) | US7309700B2 (no) |
EP (1) | EP1740586A2 (no) |
JP (1) | JP2007530681A (no) |
KR (1) | KR20070014164A (no) |
CN (1) | CN1938306A (no) |
AR (1) | AR048360A1 (no) |
AU (1) | AU2005230922A1 (no) |
BR (1) | BRPI0509586A (no) |
CA (1) | CA2558817A1 (no) |
EA (1) | EA200601816A1 (no) |
EC (1) | ECSP066904A (no) |
IL (1) | IL178352A0 (no) |
MX (1) | MXPA06011324A (no) |
NO (1) | NO20064422L (no) |
PE (1) | PE20060164A1 (no) |
TW (1) | TW200602340A (no) |
UY (1) | UY28827A1 (no) |
WO (1) | WO2005097796A2 (no) |
ZA (1) | ZA200605930B (no) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2640627A1 (en) * | 2006-01-31 | 2007-08-09 | Thallion Pharmaceuticals Inc. | Crystalline forms of a farnesyl dibenzodiazepinone |
CN109384765A (zh) * | 2012-09-26 | 2019-02-26 | 默沙东公司 | 逆转录酶抑制剂的晶型 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI270547B (en) * | 2000-06-16 | 2007-01-11 | Boehringer Ingelheim Ca Ltd | Non-nucleoside reverse transcriptase inhibitors |
US6759533B2 (en) | 2002-06-28 | 2004-07-06 | Boehringer Ingelheim Pharmaceuticals, Inc. | Process and intermediates for making non-nucleoside HIV-1 reverse transcriptase inhibitors |
-
2005
- 2005-03-18 US US11/083,401 patent/US7309700B2/en active Active
- 2005-03-23 BR BRPI0509586-7A patent/BRPI0509586A/pt not_active Application Discontinuation
- 2005-03-23 CA CA002558817A patent/CA2558817A1/en not_active Abandoned
- 2005-03-23 WO PCT/US2005/009655 patent/WO2005097796A2/en active Application Filing
- 2005-03-23 EP EP05729416A patent/EP1740586A2/en not_active Withdrawn
- 2005-03-23 JP JP2007506248A patent/JP2007530681A/ja active Pending
- 2005-03-23 AU AU2005230922A patent/AU2005230922A1/en not_active Abandoned
- 2005-03-23 MX MXPA06011324A patent/MXPA06011324A/es unknown
- 2005-03-23 CN CNA2005800104438A patent/CN1938306A/zh active Pending
- 2005-03-23 EA EA200601816A patent/EA200601816A1/ru unknown
- 2005-03-23 KR KR1020067023046A patent/KR20070014164A/ko not_active Application Discontinuation
- 2005-03-30 UY UY28827A patent/UY28827A1/es not_active Application Discontinuation
- 2005-03-31 PE PE2005000373A patent/PE20060164A1/es not_active Application Discontinuation
- 2005-04-01 AR ARP050101292A patent/AR048360A1/es unknown
- 2005-04-01 TW TW094110415A patent/TW200602340A/zh unknown
-
2006
- 2006-07-18 ZA ZA200605930A patent/ZA200605930B/xx unknown
- 2006-09-28 IL IL178352A patent/IL178352A0/en unknown
- 2006-09-29 NO NO20064422A patent/NO20064422L/no not_active Application Discontinuation
- 2006-10-02 EC EC2006006904A patent/ECSP066904A/es unknown
Also Published As
Publication number | Publication date |
---|---|
ZA200605930B (en) | 2007-12-27 |
EP1740586A2 (en) | 2007-01-10 |
AU2005230922A1 (en) | 2005-10-20 |
EA200601816A1 (ru) | 2007-04-27 |
UY28827A1 (es) | 2005-10-31 |
PE20060164A1 (es) | 2006-04-03 |
AR048360A1 (es) | 2006-04-19 |
WO2005097796A3 (en) | 2006-01-05 |
IL178352A0 (en) | 2007-02-11 |
US20050222134A1 (en) | 2005-10-06 |
TW200602340A (en) | 2006-01-16 |
MXPA06011324A (es) | 2007-03-21 |
BRPI0509586A (pt) | 2007-10-09 |
US7309700B2 (en) | 2007-12-18 |
JP2007530681A (ja) | 2007-11-01 |
ECSP066904A (es) | 2006-12-20 |
CN1938306A (zh) | 2007-03-28 |
WO2005097796A2 (en) | 2005-10-20 |
CA2558817A1 (en) | 2005-10-20 |
KR20070014164A (ko) | 2007-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1103091A1 (en) | Methanesulfonate salts of abiraterone-3-esters and recovery of salts of abiraterone-3-esters from solution in methyl tert-butyl ether | |
WO2007015017A3 (fr) | Nouveaux derives de polyquinoleines et leur utilisation therapeutique | |
WO2007123995A3 (en) | Camptothecin-analog with a novel, “flipped” lactone-stable, e-ring and methods for making and using same | |
WO2007061737A3 (en) | FUSED BICYCLIC mTOR INHIBITORS | |
WO2008120725A1 (ja) | 新規ピロリノン誘導体およびそれを含有する医薬組成物 | |
UA94065C2 (en) | Dihydropseudoerythromycin derivatives | |
WO2007048066A3 (en) | Pyrazolo-pyrimidines as casein kinase ii (ck2) modulators | |
MX2007006397A (es) | Derivados de tetrahidropirano. | |
WO2006011050A3 (en) | Pyridine derivatives | |
WO2006102308A3 (en) | Beta-lactamyl vasopressin v1b antagonists | |
WO2005080352A3 (en) | Quinazoline derivatives and therapeutic use thereof | |
WO2007075964A3 (en) | Thrombin receptor antagonists as prophylaxis to complications from cardiopulmonary surgery | |
NO20063576L (no) | 1,3-dioksanederivativer og analoge forbindelser for behandling av fedme og diabetes | |
WO2007011878A8 (en) | Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists | |
MX2007006387A (es) | Derivados de piridina 3-substituidos como antagonistas h3. | |
HK1105977A1 (en) | Pyrrolo [3,2-c] pyridine derivatives and processes for the preparation | |
NO20073854L (no) | Doseringsform og fremgangsmate for vedvarende frigjoring av en substituert pyrazinforbindelse | |
WO2007010356A3 (en) | Process for the preparation of sulfonamide derivatives | |
WO2006036932A3 (en) | Sulfonamides and uses thereof | |
MX2007002833A (es) | Derivados de alquiliden-tetrahidronaftaleno, procedimiento para su preparacion y su uso como antiinflamatorios. | |
IL195837A0 (en) | 4-amino-3-arylamino-6-arylpyrazolo[3,4-d] | |
NO20064422L (no) | Krystallinske former av 5,11-dihydro-11-etyl-5-metyl-8{2-{(1-oksido-4-kinolin 1)oksy}etyl}-6H-dipyrido[3,2-B:2',3'-E][1,4]diazepin--on | |
CY2011018I1 (el) | Νεα κρυσταλλικη μορφη toy 8-kyan-1-kykλoπpoπyλ-7-(1s,6s-2,8-διαζαδικυκλο[4.3.0]εννεαν-8-υλ)-6-φθορο-1,4-διυδρο-4-οξο-3-κινολινο-καρβοξυλικου οξεος | |
HK1105978A1 (en) | Pyrrolo [3,2-c]pyridine derivatives and processes for the preparation thereof | |
WO2005102308A3 (en) | Crystalline and amorphous forms of efaproxiral sodium |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |